Emulate
Human biology on a chip.
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- emulatebio.com
- Total Funding
- $203.0M
- Last Round
- $82.0M Series ESep 2021
- Rounds
- 6
About
Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, spun out of Harvard's Wyss Institute in 2013. The company commercializes its Human Emulation System — microfluidic chips lined with living human cells that replicate organ-level biology — enabling pharmaceutical and biotech researchers to model disease and test drug candidates.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...